Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
Toyama K, Yaguchi M, Mizoguchi H, Masuda M, Urabe A, Ikeda Y, Aoki I, Shinbo T, Togawa A, Hirashima K, Miura Y, Hirose S, Tsuruoka N, Omine M, Kamakura M, Saito T, Arimori S, Aoki N, Kuraishi Y, Hirai H, Asano S, Mori M, Shirai T, Muto Y, Takaku F, et al.
Toyama K, et al. Among authors: ikeda y.
Kansenshogaku Zasshi. 1996 Dec;70(12):1242-53. doi: 10.11150/kansenshogakuzasshi1970.70.1242.
Kansenshogaku Zasshi. 1996.
PMID: 9011117
Clinical Trial.